feed,title,long_url,short_url
Investors,GSK Crumbles As Blood Cancer Comeback Falls Unexpectedly Short,https://www.investors.com/news/technology/gsk-stock-blenrep-approval-multiple-myeloma-treatment/,
Investors,Why Ford Stock Is Rising Even As EV Division Loses $1.4 Billion Amid 'Model T' Push,https://www.investors.com/news/ford-stock-is-rising-stock-market-despite-profit-decline/,
